AMT vs CGEM · P/E 31, rev $2.55B vs $830.3M cap
American Tower Corp (AMT) versus Cullinan Oncology LLC (CGEM) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Cullinan Oncology LLC (CGEM) is a biotechnology company listed on US.
Latest reported AMT revenue for 2024-12-31 was $2.55B. Net income was $2.28B. Revenue was up 1.0% from 2024-09-30 to 2024-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
Latest reported CGEM revenue for 2022-12-31 was $0. Net income was $109.2M. CGEM currently screens at market cap $830.3M.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. CGEM currently screens at market cap $830.3M.
Not investment advice. Open the AMT and CGEM stock pages for the full models.
Not investment advice.